https://orcid.org/0000-0003-2819-3484
References
- Pollock RF, Biggar P. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia. Expert Rev Hematol, 13:2, 187–195.
- Pharmacosmos A/S. Iron isomaltoside and iron sucrose for the treatment of iron deficiency anemia in non-dialysis-dependent chronic kidney disease. NCT02940860. [cited 2019 Oct 1]. Available from: https://clinicaltrials.gov/ct2/show/NCT02940860.
- Pharmacosmos A/S. An extension trial to assess the safety of redosing of iron isomaltoside (Monofer®) (FerWonExt). October 1, 2019 [cited 2019 Sept 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT02962648.
- Adkinson NF, Strauss WE, Macdougall IC, et al. Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: a randomized trial. Am J Hematol. 2018;93:683–690.
- Allen RP, Adler CH, Du W, et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Med. 2011;12:906–913.
- Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436–2448.
- Bailie GR, Mason NA, Valaoras TG. Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Hemodial Int. 2010;14:47–54.
- Breymann C, Milman N, Mezzacasa A, et al. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 2017;45:443–453.
- Higgins JGS, Cochrane Handbook for Systematic Reviews of Interventions; Version 5.1.0 March 2011].
- Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer(R)) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang. 2015;109:257–266.
- Laso-Morales MJ, Vives R, Vallejo-Tarrat A, et al. Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial 11 medical and health sciences 1103 clinical sciences. Trials. 2019;20:20.
- Reinisch W, Altorjay I, Zsigmond F, et al. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scand J Gastroenterol. 2015;50:1226–1233.